Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment-Reference-Cited by-同舟云学术

Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment

Published:2021-06-23 Issue:2 Volume:13 Page:168-170
ISSN:2041-4137
Container-title:Frontline Gastroenterology
language:en
Short-container-title:Frontline Gastroenterol

Author:

Sriranganathan Danujan^ORCID,Segal Jonathan P^ORCID,Garg Mayur

Abstract

In 2019, the European Crohn’s and Colitis Organisation released guidelines for the medical management of Crohn’s disease, concerning the induction of remission, the maintenance of remission and the treatment of fistulising perianal disease. This review summarises the key recommendations regarding the use of biologics in these settings.

Publisher

BMJ

Subject

Gastroenterology,Hepatology

Reference17 articles.

1. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

2. Infliximab, Azathioprine, or Combination Therapy for Crohn’s Disease;Colombel;N Engl J Med Overseas Ed,2010

3. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

4. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study;Kennedy;Lancet Gastroenterol Hepatol,2019

5. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Cannabis Increases Appetite but Not Body Weight in Patients with Inflammatory Bowel Diseases;Nutrients;2023-12-26

2. Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology;PLOS ONE;2023-12-13

3. Bioadhesive Microcarriers Encapsulated with IL‐27 High Expressive MSC Extracellular Vesicles for Inflammatory Bowel Disease Treatment;Advanced Science;2023-09-27

4. Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn's disease: a meta-analysis based on randomized controlled trials;2023-09-05

5. Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn’s disease: A meta-analysis based on randomized controlled trials;Central European Journal of Immunology;2023